In the BioHarmony Drug Report Database

"Preview" Icon

Belimumab

Benlysta (belimumab) is an antibody pharmaceutical. Belimumab was first approved as Benlysta on 2011-03-09. It is used to treat systemic lupus erythematosus in the USA. It has been approved in Europe to treat systemic lupus erythematosus. The pharmaceutical is active against tumor necrosis factor ligand superfamily member 13B.

 

Trade Name

 

Benlysta
 

Common Name

 

belimumab
 

ChEMBL ID

 

CHEMBL1789843
 

Indication

 

systemic lupus erythematosus
 

Drug Class

 

Monoclonal antibodies

Image (chem structure or protein)

Belimumab structure rendering